Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $952,621 (99.4% shares, 0.6% debt)

Holdings (18)

VTI VANGUARD INDEX FDS 24.2%

Value ($000) $230,941 Shares 2,155,100 Est. Cost $57.39 Unrealized —

— OPHTHOTECH CORP 19.3%

Value ($000) $184,243 Shares 3,610,487 Est. Cost $32.35 Unrealized —

INGN INOGEN INC 18.7%

Value ($000) $177,856 Shares 3,549,320 Est. Cost $17.78 Unrealized +168.2%

VGK VANGUARD INTL EQUITY INDEX F 10.3%

Value ($000) $98,033 Shares 2,101,000 Est. Cost $45.01 Unrealized —

— REATA PHARMACEUTICALS INC 7.0%

Value ($000) $66,513 Shares 3,367,763 Est. Cost $19.75 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 4.8%

Value ($000) $45,975 Shares 3,224,046 Est. Cost $14.33 Unrealized -5.7%

— TOBIRA THERAPEUTICS INC 2.7%

Value ($000) $25,460 Shares 2,027,091 Est. Cost $17.25 Unrealized —

— COLUCID PHARMACEUTICALS INC 2.6%

Value ($000) $24,972 Shares 3,056,563 Est. Cost $8.90 Unrealized —

— ACCELERON PHARMA INC 2.4%

Value ($000) $23,306 Shares 685,863 Est. Cost $26.53 Unrealized —

— SPECTRANETICS CORP 2.2%

Value ($000) $20,899 Shares 1,117,002 Est. Cost $17.82 Unrealized —

— FLEXION THERAPEUTICS INC 1.5%

Value ($000) $14,224 Shares 950,161 Est. Cost $14.97 Unrealized —

— MERUS N V 1.2%

Value ($000) $11,269 Shares 1,410,417 Est. Cost $7.99 Unrealized —

— INVUITY INC 1.1%

Value ($000) $10,249 Shares 1,075,448 Est. Cost $8.89 Unrealized —

— NABRIVA THERAPEUTICS AG 0.8%

Value ($000) $7,911 Shares 1,054,823 Est. Cost $9.16 Unrealized —

— WRIGHT MED GROUP N V 0.6%

Value ($000) $5,824 Shares 4,622,032 Est. Cost $1.25 Unrealized —

— HTG MOLECULAR DIAGNOSTICS INC 0.4%

Value ($000) $3,482 Shares 1,280,185 Est. Cost $11.15 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.1%

Value ($000) $753 Shares 127,563 Est. Cost $14.68 Unrealized -53.3%

— TOKAI PHARMACEUTICALS INC 0.1%

Value ($000) $711 Shares 128,993 Est. Cost $14.41 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,155,100	$230,941	24.2%	$57.39	—	TOTAL STK MKT	922908769
—	OPHTHOTECH CORP	3,610,487	$184,243	19.3%	$32.35	—	COM	683745103
INGN	INOGEN INC	3,549,320	$177,856	18.7%	$17.78	+168.2%	COM	45780L104
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$98,033	10.3%	$45.01	—	FTSE EUROPE ETF	922042874
—	REATA PHARMACEUTICALS INC	3,367,763	$66,513	7.0%	$19.75	—	CL A	75615P103
CRVS	CORVUS PHARMACEUTICALS INC	3,224,046	$45,975	4.8%	$14.33	-5.7%	COM	221015100
—	TOBIRA THERAPEUTICS INC	2,027,091	$25,460	2.7%	$17.25	—	COM	88883P101
—	COLUCID PHARMACEUTICALS INC	3,056,563	$24,972	2.6%	$8.90	—	COM	19716T101
—	ACCELERON PHARMA INC	685,863	$23,306	2.4%	$26.53	—	COM	00434H108
—	SPECTRANETICS CORP	1,117,002	$20,899	2.2%	$17.82	—	COM	84760C107
—	FLEXION THERAPEUTICS INC	950,161	$14,224	1.5%	$14.97	—	COM	33938J106
—	MERUS N V	1,410,417	$11,269	1.2%	$7.99	—	COM	N5749R100
—	INVUITY INC	1,075,448	$10,249	1.1%	$8.89	—	COM	46187J205
—	NABRIVA THERAPEUTICS AG	1,054,823	$7,911	0.8%	$9.16	—	COM	62957M104
—	WRIGHT MED GROUP N V	4,622,032	$5,824	0.6%	$1.25	—	RIGHT 03/01/2019	N96617126
—	HTG MOLECULAR DIAGNOSTICS INC	1,280,185	$3,482	0.4%	$11.15	—	COM	40434H104
XENE	XENON PHARMACEUTICALS INC	127,563	$753	0.1%	$14.68	-53.3%	COM	98420N105
—	TOKAI PHARMACEUTICALS INC	128,993	$711	0.1%	$14.41	—	COM	88907J107